USPTO Examiner BOSWORTH KAMI A - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18905106CATHETERS AND RELATED METHODS FOR THE ASPIRATION CONTROLLED DELIVERY OF CLOSURE AGENTSOctober 2024May 2025Allow721YesNo
18819625Medicament Delivery DeviceAugust 2024April 2025Allow711YesNo
18718807DEVICE FOR A MEDICAL TREATMENT APPARATUS FOR MEASURING THE FLOW OF FLUIDS IN A LUMEN TO BE INSERTED, AND ENSEMBLE HAVING A CORRESPONDING DEVICE AND A LUMENJune 2024February 2026Allow2031YesNo
18715519PERITONEAL DIALYSIS SYSTEM HAVING PHASE CHANGE MATERIAL ("PCM") HEAT EXCHANGEMay 2024May 2025Allow1211NoNo
18589843PROCESSES AND DEVICES FOR DELIVERY OF FLUID BY CHEMICAL REACTIONFebruary 2024January 2026Abandon2211NoNo
18434766STEERABLE GUIDE CATHETERFebruary 2024November 2025Allow2120NoNo
18568476ONLINE FLUID GENERATING PERITONEAL DIALYSIS CYCLERDecember 2023May 2025Allow1820NoNo
18515701TREATMENT INTERVALS FOR USE OF COMPOSITIONS COMPRISING ENERGY ABSORBING MATERIALS FOR DERMATOLOGICAL APPLICATIONSNovember 2023April 2025Allow1711NoNo
18504818NEEDLE SHIELD GRIP DEVICES AND RELATED METHODSNovember 2023October 2025Allow2322YesNo
18380942SLIDING FLOW CONTROLLEROctober 2023October 2024Allow1220NoNo
18377604FLUSH ENHANCING MALE LUER TIP DESIGN FOR SYRINGES AND ANY LUER CONNECTOROctober 2023August 2025Allow2321YesNo
18482152RESERVOIR FOR MEDICAL IMPLANTSOctober 2023May 2024Allow821NoNo
18481857DEVICE, SYSTEM AND METHODS FOR THE ORAL DELIVERY OF THERAPEUTIC COMPOUNDSOctober 2023November 2024Allow1411NoNo
18467049Catheter Insertion DevicesSeptember 2023February 2026Allow2930YesNo
18242279SMART DIALYSIS BAG DETECTION SYSTEMSeptember 2023May 2025Allow2011NoNo
18238078INJECTION NEEDLE ASSEMBLYAugust 2023June 2025Allow2220NoNo
18365180NEEDLELESS ACCESS CONNECTORS AND VALVE ELEMENTS THEREFORAugust 2023July 2024Allow1210YesNo
18272680OCULAR PLATFORMS AND SURGICAL TOOLSJuly 2023October 2025Allow2710NoNo
18215869MEDICAL DEVICE WITH A THERMAL MASS FLOW SENSOR FOR BUBBLE DETECTIONJune 2023February 2025Allow1911NoNo
18269823PERITONEAL DIALYSIS CYCLER HAVING HEAT CLEANINGJune 2023August 2024Allow1430NoNo
18269850DURABLE, MULTI-USE PERITONEAL DIALYSIS CYCLER USING DISINFECTIONJune 2023June 2024Allow1200NoNo
18208663CAPACITIVE PRIMING SENSOR FOR A MEDICAL FLUID DELIVERY SYSTEMJune 2023June 2025Allow2421NoNo
18326915COUPLING MECHANISMS FOR MEDICAL DEVICESMay 2023January 2026Allow3241NoNo
18301159MEDICAL DEVICES FOR FLUID DELIVERY AND METHODS OF USE AND MANUFACTUREApril 2023November 2024Allow2010NoNo
18134148SUBCUTANEOUS INFUSION NEEDLE STICK PREVENTION DEVICE USING NEEDLE HUB RETRACTIONApril 2023August 2024Allow1601NoNo
18110041Balloon Catheter Systems for Delivery of Dry Drug Delivery Vesicles to a Vessel in the BodyFebruary 2023July 2024Allow1701NoNo
18085095METHOD OF INJECTING OCTREOTIDE ACETATE INTO THE BODYDecember 2022April 2025Allow2820YesNo
18076101PIEZOELECTRIC MEMBRANE PUMP FOR THE INFUSION OF LIQUIDSDecember 2022October 2025Abandon3411NoNo
17993302DIALYSIS SYSTEMS AND METHODS INCLUDING SENSOR FEEDBACK TO IMPROVE PATIENT EXPERIENCENovember 2022March 2024Allow1500NoNo
18054252MULTI CHAMBER FLEXIBLE BAG AND METHODS OF USING SAMENovember 2022April 2023Allow510NoNo
17980189SYSTEMS AND METHODS FOR IMPROVING FLUID FLOW DURING MEDICATION DELIVERY PROCEDURESNovember 2022September 2024Allow2210NoNo
17980173SYSTEMS AND METHODS FOR IMPROVING FLUID FLOW DURING MEDICATION DELIVERY PROCEDURESNovember 2022March 2025Allow2821NoNo
17964766INTERVENTIONAL MEDICAL DEVICE WITH BALLOON-ACTUATED COVEROctober 2022September 2025Allow3601YesNo
17938559BALLOON CATHETERS AND METHODS OF MANUFACTURE AND USEOctober 2022November 2025Allow3721NoNo
17958651CATHETER WITH REDUCED CONTACT SURFACEOctober 2022February 2026Abandon4110NoNo
17913147A BALLOON CATHETER ASSEMBLY TO PROVIDE BLOOD IN INFLATABLE CONDITIONSeptember 2022February 2026Abandon4110NoNo
17930000MEDICAL DEVICES FOR FLUID DELIVERY AND METHODS OF USE AND MANUFACTURESeptember 2022April 2023Allow710NoNo
17929949MEDICAL DEVICES FOR FLUID DELIVERY AND METHODS OF USE AND MANUFACTURESeptember 2022April 2023Allow710NoNo
17899748TUBE SET SEAL ASSEMBLYAugust 2022February 2026Allow4111NoNo
17800257Adaptor for Mounting onto a Medical Container, a Medical Container Comprising Said Adaptor, and a Method for Manufacturing Said AdaptorAugust 2022December 2025Allow4020YesNo
17800302Adaptor for a Medical Container, a Medical Container Comprising Said Adaptor, and a Method for Manufacturing Said AdaptorAugust 2022March 2026Allow4320NoNo
17798641MEDICAMENT DELIVERY DEVICE WITH A LOCKING MECHANISMAugust 2022August 2025Allow3610NoNo
17816779CATHETER AND METHOD FOR CONTROLLING THE CATHETERAugust 2022August 2025Allow3610NoNo
17795372INSERTION DEVICE AND ASSEMBLY COMPRISING SUCH INSERTION DEVICE AND A FLEXIBLE IMPLANTABLE STRIPJuly 2022January 2026Abandon4210NoNo
17869331SYRINGE SET AND SYRINGE HAVING A REMOVABLE BLOCKING MEMBERJuly 2022September 2025Allow3810NoNo
17793547CONTRAST AGENT INJECTION DEVICE AND INJECTION LINE KITJuly 2022January 2026Abandon4201NoNo
17860176PERCUTANEOUS RENAL ACCESS SYSTEMJuly 2022January 2026Abandon4301NoNo
17790205SMART CONNECTOR FOR CONNECTING PATIENT TO MEDICAL PRODUCTJune 2022February 2026Allow4310NoNo
17809536Catheters with Expandable and Collapsible LumensJune 2022January 2026Abandon4210NoNo
17851125INJECTION FLUID QUANTIFICATIONJune 2022June 2024Allow2411NoNo
17785326INJECTION PUMP NEEDLE MECHANICSJune 2022January 2026Abandon4310NoNo
17783815METHODS AND DEVICES FOR DELIVERING LIQUID THERAPEUTIC AGENTS IN SOLID TUMORSJune 2022January 2026Abandon4310NoNo
17756944Intermediate Suction CatheterJune 2022March 2026Allow4521YesNo
17831134AUDIBLE INDICATORJune 2022February 2024Allow2010NoNo
17826524VALVE BODY AND MEDICAL INSTRUMENT PROVIDED WITH VALVE BODYMay 2022November 2025Allow4210NoNo
17804166OPTIMIZED BEDSIDE SAFETY PROTOCOL SYSTEMMay 2022July 2025Allow3711NoNo
17767936SAFE EJECTION INTRAVENOUS NEEDLEMay 2022March 2023Allow1110NoNo
17663620DEVICE FOR TRANSFERRING AND CONDITIONING INFUSION LIQUID AND RELATED TECHNOLOGYMay 2022August 2025Allow3910YesNo
17743558Vented Connector for Medical Fluid Vessels and Tapered PlugMay 2022November 2024Allow3030YesNo
17774566COUPLING SYSTEM FOR A CLOSED FLUID TRANSFER SYSTEMMay 2022February 2026Allow4520NoNo
17774029A BALLOON DEVICE AND A MEDICAL DEVICE COMPRISING ITMay 2022October 2025Allow4120NoNo
17661724IRRIGATION AND ASPIRATION DEVICE AND METHODMay 2022June 2024Abandon2510NoNo
17734162APPARATUS FOR SUBRETINAL ADMINISTRATION OF THERAPEUTIC AGENT VIA A CURVED NEEDLEMay 2022May 2025Abandon3731YesNo
17773390MEDICINAL LIQUID SUPPLY CONTROL APPARATUS, RESERVOIR ASSEMBLY FOR MEDICINAL LIQUID SUPPLY CONTROL APPARATUS, AND MEDICINAL LIQUID INJECTION APPARATUS INCLUDING SAMEApril 2022February 2026Abandon4501NoNo
17659375Catheters with Expandable and Collapsible LumensApril 2022April 2025Allow3600NoNo
17768425A CATHETER DEVICE COMPRISING A LEVERING MEMBERApril 2022August 2024Allow2820NoNo
17719111Peritoneal Dialysis Systems, Devices, and MethodsApril 2022November 2024Allow3111NoNo
17675860BUTTON SAFETY CAP FOR CATHETER INSERTION DEVICEFebruary 2022March 2025Allow3720NoNo
17636562CATHETERS AND METHODS OF MANUFACTURE AND USEFebruary 2022April 2025Allow3810NoNo
17583976SAFETY HOUSING BASED IMPLANT/MEDICAMENT INJECTING SYSTEMJanuary 2022July 2024Allow3011NoNo
17583995SAFETY HOUSING BASED IMPLANT/MEDICAMENT INJECTING SYSTEMJanuary 2022July 2024Allow2911NoNo
17583965SAFETY HOUSING BASED IMPLANT/MEDICAMENT INJECTING SYSTEMJanuary 2022July 2024Allow2911NoNo
17628089DEVICES FOR SAFE AND RELIABLE ACCESS TO SUB ARACHNOID AND SUBDURAL SPACEJanuary 2022January 2026Abandon4811NoNo
17564772METHOD OF INJECTING OCTREOTIDE ACETATE INTO THE BODYDecember 2021September 2022Allow920YesNo
17542166Anti-Reflux Plug Forming Detachable Tip MicrocatheterDecember 2021October 2024Allow3420NoNo
17523168DEVICE FOR OCULAR ACCESSNovember 2021April 2024Allow2931YesYes
17608912DRUG SOLUTION ADMINISTRATION UNIT, DRUG SOLUTION ADMINISTRATION MODULE, DRUG SOLUTION ADMINISTRATION DEVICE, AND MEDICATION MANAGEMENT SYSTEMNovember 2021September 2024Allow3510YesNo
17519472SMART CONNECTION INTERFACENovember 2021February 2025Allow3920YesNo
17452381METHOD AND APPARATUS FOR DELIVERY OF THERAPEUTIC AGENTSOctober 2021February 2026Allow5240YesNo
17488104DELIVERY SYSTEMS AND METHOD THEREOFSeptember 2021December 2025Abandon5101NoNo
17480969ADDITIVE PNEUMATIC MANIFOLDSeptember 2021October 2025Allow4931YesNo
17440556MEDICAL INSTRUMENT WITH INJECTION NEEDLESSeptember 2021June 2025Allow4530NoNo
17412846Dialysis Systems, Devices, and MethodsAugust 2021March 2023Allow1940YesNo
17405214INSERTER, MEDICAL ELONGATED BODY SET THAT INCLUDES INSERTER, AND METHOD OF USING INSERTERAugust 2021July 2025Allow4721NoNo
17403614Dialysis Systems, Devices, and MethodsAugust 2021May 2022Allow910NoNo
17403600Dialysis Systems, Devices, and MethodsAugust 2021May 2022Allow910NoNo
17394121MANAGEMENT OF INSUFFICIENT HYPOGLYCEMIA RESPONSEAugust 2021April 2024Allow3211YesNo
17394259SYSTEM AND METHOD FOR THE DELIVERY OF MEDICATIONS OR FLUIDS TO THE EYEAugust 2021January 2024Abandon2910NoNo
17381594TECHNIQUES FOR COLLECTING DIALYSIS EFFLUENT TARGET MATERIALSJuly 2021July 2025Abandon4831YesNo
17377633PUMP ASSEMBLY WITH SWITCHJuly 2021October 2025Allow5151NoNo
17371685EXPANDABLE-MOUTH CATHETER INTRODUCER TOOLJuly 2021September 2024Allow3830YesNo
17367393Hub Assembly with a Self-Closing Valve for Use with a SyringeJuly 2021July 2024Allow3720NoNo
17363325METHOD OF INJECTING OCTREOTIDE ACETATE INTO THE BODYJune 2021October 2021Allow401NoNo
17360589TUBING MARKERSJune 2021February 2025Abandon4420NoNo
17359280FLUID REPLACEMENT DEVICEJune 2021February 2024Allow3221YesNo
17356948Method and Apparatus for Controlled Relative Motion of Surgical Instruments and ComponentsJune 2021February 2025Allow4321YesNo
17342763CATHETER ASSEMBLYJune 2021August 2025Abandon5021NoNo
17343004CATHETER WITH ENHANCED TENSILE STRENGTHJune 2021October 2021Allow510NoNo
17330856PEEL AWAY HEMOSTASIS VALVEMay 2021October 2025Allow5340NoNo
17329944PERSONALIZABLE SYSTEM AND METHOD FOR ANESTHETIZING TYMPANIC MEMBRANEMay 2021January 2024Abandon3231NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BOSWORTH, KAMI A.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
8
Examiner Affirmed
6
(75.0%)
Examiner Reversed
2
(25.0%)
Reversal Percentile
41.8%
Lower than average

What This Means

With a 25.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
35
Allowed After Appeal Filing
7
(20.0%)
Not Allowed After Appeal Filing
28
(80.0%)
Filing Benefit Percentile
26.5%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 20.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner BOSWORTH, KAMI A - Prosecution Strategy Guide

Executive Summary

Examiner BOSWORTH, KAMI A works in Art Unit 3783 and has examined 407 patent applications in our dataset. With an allowance rate of 74.7%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 36 months.

Allowance Patterns

Examiner BOSWORTH, KAMI A's allowance rate of 74.7% places them in the 39% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by BOSWORTH, KAMI A receive 2.88 office actions before reaching final disposition. This places the examiner in the 84% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by BOSWORTH, KAMI A is 36 months. This places the examiner in the 37% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +19.1% benefit to allowance rate for applications examined by BOSWORTH, KAMI A. This interview benefit is in the 62% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 20.3% of applications are subsequently allowed. This success rate is in the 22% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 39.3% of cases where such amendments are filed. This entry rate is in the 60% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 75.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 61% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 75.0% of appeals filed. This is in the 67% percentile among all examiners. Of these withdrawals, 54.2% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 50.0% are granted (fully or in part). This grant rate is in the 49% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.2% of allowed cases (in the 54% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.